ACADIA Pharmaceuticals (ACAD)

13.79 -0.36  -2.54%  May 21, 5:00PM
Add to Watchlists Create an Alert

ACADIA Pharmaceuticals Debt to Equity Ratio:

0.00 for Dec. 31, 2012
View Full Chart

ACADIA Pharmaceuticals Debt to Equity Ratio Chart

    ACADIA Pharmaceuticals Historical Debt to Equity Ratio Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 0.00
    Sept. 30, 2012 0.0002
    June 30, 2012 0.001
    March 31, 2012 0.0013
    Dec. 31, 2011 0.0014
    Sept. 30, 2011 0.0013
    June 30, 2011 0.0012
    March 31, 2011 0.0012
    Dec. 31, 2010 0.0037
    Sept. 30, 2010
    June 30, 2010 0.0672
    March 31, 2010 0.0502
    Dec. 31, 2009 0.0382
    Sept. 30, 2009 0.0318
    June 30, 2009 0.0298
    March 31, 2009 0.0263
    Dec. 31, 2008 0.0231
    Sept. 30, 2008 0.0208
       
    June 30, 2008 0.0199
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro

    About Debt to Equity Ratio

    Leverage ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. A low debt to equity ratio indicates lower risk, because debt holders have less claims on the company's assets. A debt to equity ratio of 5 means that debt holders have a 5 times more claim on assets than equity holders.

    A high debt to equity ratio usually means that a company has been aggressive in financing growth with debt and often results in volatile earnings.

    It is also known as Debt/Equity Ratio, Debt-Equity Ratio, and D/E Ratio.
    Learn More

    Get data for

    ACAD Debt to Equity Ratio Benchmarks

    Companies
    Insmed 0.1591
    Arena Pharmaceuticals 0.00
    Sarepta Therapeutics 0.0142

    ACAD Debt to Equity Ratio Rankings

    Overall 99th percentile
    1 of 8002
    Sector 99th percentile
    1 of 684 in Healthcare
    Industry 99th percentile
    1 of 248 in Biotechnology

    ACAD Debt to Equity Ratio Range, Past 5 Years

    Minimum 0.00 Dec 2012
    Maximum 0.0672 Jun 2010
    Average 0.0177